Consider what happens to a Medicare beneficiary after a hospitalization. She is 74, recovering from a hip fracture. Her orthopedic surgeon recommends a transfer to a skilled nursing facility for two to three weeks of rehabilitation before she returns home — intensive physical therapy, nursing oversight, wound care. Her physician documents medical necessity. The hospital discharge planner submits the prior authorization request to her Medicare Advantage plan.
The plan denies it.
The denial says the clinical documentation does not support the need for skilled nursing facility care. It offers home health services instead. The patient’s physician disagrees. The hospital’s care team disagrees. The prior authorization review was conducted by an algorithm — not a physician — in a fraction of a second.
That scenario is not hypothetical. It is the documented pattern the federal government’s own investigators found when they examined Medicare Advantage prior authorization denials for post-acute care.
What OIG Found
In April 2022, the Department of Health and Human Services Office of Inspector General published a report examining prior authorization and payment denials by the 15 largest Medicare Advantage organizations — a group covering nearly 80 percent of all MA beneficiaries. The study examined a stratified random sample of prior authorization requests and payment denials from a week in June 2019.
The findings were direct. OIG found that 13 percent of prior authorization requests denied by MA plans met Medicare coverage criteria — meaning these were services that traditional Medicare would likely have approved for the same beneficiaries. OIG found that 18 percent of payment requests denied by MA plans met Medicare coverage criteria — meaning nearly one in five denied payment requests involved care that Medicare would have covered.
The denials were not random across service types. They were concentrated in specific categories: post-acute care transfers to skilled nursing facilities and inpatient rehabilitation facilities, advanced imaging services such as MRIs, and injections. These are among the highest-cost services in the post-acute and outpatient settings — which is also where the financial incentive to deny is greatest for an insurer receiving a fixed capitated payment.
OIG’s physician reviewers — the panel that evaluated whether the denied services met Medicare coverage criteria — found that in the post-acute care cases, the patients would have clinically benefited from the higher level of care that was denied. The alternative services the MA plans offered as substitutes were, in the clinical reviewers’ judgment, insufficient.
The OIG report includes specific documented cases. In one, a Medicare Advantage plan denied a prior authorization request for an MRI of a beneficiary’s hand — estimated cost $365 — five months after a fall, when the patient continued to experience pain and weakness. The plan cited its internal clinical criteria requiring that the beneficiary first undergo an x-ray that failed to provide a diagnosis before it would authorize the MRI. OIG’s physician reviewers found the underlying medical records already in the case file were sufficient to support medical necessity. The plan’s criteria, not the clinical evidence, drove the denial. MA plans applying clinical criteria more restrictive than Medicare’s coverage rules; plans requiring documentation beyond what Medicare standards require; and errors in both manual and automated review processes.
The report stated the structural problem plainly: “Capitated payment models, such as Medicare Advantage, can create an incentive for MAOs to deny the prior authorization of services for beneficiaries and payments to providers, including some services and payments that would not have been denied under Medicare.”
The Financial Logic
The OIG finding is significant precisely because it is not surprising. It is the predictable consequence of the financial architecture documented in the preceding articles of this hub.
A Medicare Advantage insurer receives a fixed monthly capitated payment for each enrollee regardless of what care is delivered. The margin between the capitated payment and the cost of care determines the insurer’s profit on that enrollee. A skilled nursing facility authorization for a post-hospitalization hip fracture patient — two to three weeks of intensive rehabilitation at costs that can exceed $600 per day — is a major reduction in that margin. A denial, or a substitution of less expensive home health services, preserves it.
Prior authorization is the operational mechanism by which that financial logic is applied at the individual level. The insurer does not choose between caring for the patient well and making money — it has built a system that makes those decisions at scale, algorithmically, at the point where the financial stakes are highest. The OIG finding that 13 percent of PA denials and 18 percent of payment denials did not meet coverage criteria is the measured output of that system.
Traditional Medicare has no prior authorization requirement for skilled nursing facility transfers following a qualifying hospital stay. A beneficiary in traditional Medicare whose physician documents medical necessity and whose hospital submits the appropriate certification is covered. No insurer reviews the request and applies clinical criteria more restrictive than Medicare’s own. The coverage decision is made by the statute and the treating physicians, not by a managed care organization’s internal utilization management protocols.
The nH Predict Algorithm
UnitedHealth Group’s NaviHealth subsidiary developed an algorithm called nH Predict specifically for managing post-acute care utilization — the category of care where OIG found the most concentrated pattern of improper denials. The algorithm uses historical patient data to predict how long a post-acute care stay will typically last and to set expected discharge dates.
A federal class action complaint filed in 2023 alleged that nH Predict generated post-acute care denial rates exceeding 90 percent — denying continued skilled nursing facility stays in more than nine of every ten cases where the algorithm determined the patient had reached its predicted discharge date, regardless of the patient’s actual clinical condition or the treating team’s assessment. The complaint alleged that patients were being denied continued coverage at skilled nursing facilities while still medically qualifying for that care under Medicare criteria, and that the denial decisions were driven by the algorithm’s outputs rather than individual clinical review.
The nH Predict case is the MA-specific instance of a broader documented pattern in the commercial insurance market: algorithmic denial tools that deny at scale without meaningful individual clinical review. The Health Insurance Industry hub documents the Cigna case in which a physician reviewed an average of 1.2 seconds per claim — effectively no review — to deny claims at scale. The MA prior authorization context is the same structure applied to a population that is typically older, sicker, and more dependent on post-acute care than the commercial insurance population.
The financial stakes of the post-acute care setting make it the highest-value target for algorithmic denial. A single skilled nursing facility stay of three weeks at $600 per day represents $12,600 in claim cost. A denial rate of 90 percent across a large post-acute authorization volume represents tens of millions of dollars in preserved insurer margin per year per plan.
CMS Rulemaking: The 2023 Rule and Its Limits
The documented pattern of MA prior authorization denials exceeding Medicare coverage standards prompted regulatory action. In 2023, CMS issued a final rule requiring that Medicare Advantage organizations use Medicare coverage criteria — the same standards traditional Medicare applies — as the basis for prior authorization decisions. Plans were prohibited from applying internal clinical criteria more restrictive than Medicare’s coverage rules to justify PA denials.
The rule addressed the first of OIG’s three identified causes of improper denials: the use of more restrictive clinical criteria. It did not eliminate the financial incentive to deny, the algorithmic infrastructure built to implement denial at scale, or the second and third causes OIG identified — documentation demands and review process errors.
Implementation and compliance with the 2023 rule are ongoing questions. CMS’s enforcement capacity — the number of auditors monitoring MA prior authorization decisions across hundreds of plans and millions of authorization requests annually — limits how completely the rule can be enforced through routine oversight. Plans that continue to apply more restrictive criteria risk civil monetary penalties and audit scrutiny; the deterrent effect depends on how aggressively CMS exercises that authority.
The Improving Seniors’ Timely Access to Care Act — legislation that would have codified prior authorization reform requirements for MA plans — passed the House with broad bipartisan support but stalled in the Senate. Its provisions overlap substantially with what CMS pursued through rulemaking, but statutory authority would provide stronger enforcement footing and clearer congressional mandate.
The Appeal Gap
When a Medicare Advantage prior authorization is denied, the beneficiary has appeal rights. The process runs through several stages: redetermination by the plan, reconsideration by an independent review entity, a hearing before an administrative law judge, review by the Medicare Appeals Council, and ultimately federal court. Each stage has defined timelines and evidentiary requirements.
The appeal process is procedurally available. It is practically inaccessible for the population most affected.
A 74-year-old recovering from a hip fracture who has been denied skilled nursing facility authorization is not well-positioned to navigate a multi-stage administrative appeal. The hospital discharge planner may file a request for expedited redetermination — a 72-hour review — but the beneficiary and family are simultaneously managing a hospitalization, a discharge decision, and the immediate question of where the patient goes when the hospital bed is no longer available. The appeal process runs on a timeline that does not match the clinical urgency of a post-acute care decision.
When appeals are pursued to the administrative law judge stage, the reversal rate — the rate at which denied claims are overturned — is high, documenting systematic over-denial. High reversal rates on appeal are not evidence that the appeals process works. They are evidence that the denials that generated them should not have been issued. The vast majority of denials are never appealed — the practical barriers, the complexity, and the urgency of the underlying care situation mean that most beneficiaries absorb the denial rather than pursue the process. The appeals reversal rate is the measurement of the subset that got through. The population of improper denials that never reached appeal is substantially larger.
OIG’s own language noted that MA plans “issue millions of denials each year” with “widespread and persistent problems related to inappropriate denials of services and payment.” A congressional letter to the Biden administration citing the OIG report extrapolated that as many as 85,000 medical prior authorization requests and 1.5 million payment requests are improperly denied by MA organizations each year. Whatever the precise annual figure, the appeals process recovers a fraction of it — OIG found that plans spontaneously reversed only 3 percent of prior authorization denials, and the barriers to formal appeal mean the vast majority of improper denials are never challenged.
What the Population Experiences
The Medicare-eligible population is not the commercial insurance population. The average Medicare beneficiary is 74 years old. A significant share has multiple chronic conditions, limited mobility, and varying degrees of cognitive capacity. The population that most frequently encounters Medicare Advantage prior authorization is the population that has just had surgery, just had a heart attack, just been diagnosed with cancer — people in the acute phase of serious illness navigating the most medically complex moment of their Medicare enrollment.
The AMA’s 2025 Prior Authorization Physician Survey found that 95 percent of physicians reported that prior authorization delayed necessary care, 79 percent reported that patients abandoned recommended treatment due to prior authorization burden, and 26 percent reported that prior authorization had led to a serious adverse event for a patient.
Those findings are not MA-specific — they reflect the commercial insurance PA experience as well. But the population most exposed to prior authorization in the post-acute care setting — the hip fracture patient, the cardiac surgery recovery patient, the stroke rehabilitation patient — is the Medicare population. The AMA findings on what PA does to access translate directly to what OIG documented in the MA context: care that should be covered is being denied, delayed, or deterred, and the consequences for older patients recovering from acute illness are not recoverable in many cases.
The Gap Between Coverage and Care
Medicare Advantage enrollment advertising does not mention prior authorization as a feature of the program. The plan comparison tools that beneficiaries use during the Annual Enrollment Period display premium costs, benefit packages, and star ratings. They do not display prior authorization rates for post-acute care, denial rates for skilled nursing facility transfers, or the algorithmic tools the plan uses to make coverage decisions at the point of need.
The beneficiary who enrolls at 65 when she is healthy, attracted by the dental and vision coverage her MA plan offers, learns about the plan’s prior authorization requirements when she is 74, recovering from hip fracture surgery, and facing a denial of the skilled nursing facility stay her surgeon recommended.
At that point, she has three options: appeal through a process that is procedurally complex and practically inaccessible; accept a less appropriate level of care; or disenroll from Medicare Advantage and return to traditional Medicare — which, as Article 11 documents, may not be straightforward if she has lost her guaranteed-issue Medigap rights.
The prior authorization system is not a malfunction of the Medicare Advantage program. It is the program doing what its financial architecture requires — minimizing the cost of care delivered relative to the capitated payment received. OIG documented what that produces for individual beneficiaries at the point of greatest need. The record is clear.
The complete Medicare Advantage series
01 — What Medicare Advantage Actually Is — and How It Replaced Traditional Medicare
02 — The Political History: How Private Insurers Got Into Medicare
03 — The Marketing Machine: How Enrollment Works and Who It Targets
04 — Risk Adjustment: The Payment System That Rewards Diagnosis, Not Treatment
05 — The $84 Billion Overpayment: How Upcoding Works at Scale
06 — The Profit Extraction Model: What Insurers Take Before Care Is Delivered
07 — Prior Authorization in Medicare Advantage: What OIG Found
08 — The Denial and Appeals Record: What Happens When Enrollees Push Back
09 — Network Adequacy and the Coverage Gap
10 — The Extra Benefits Myth: Dental, Vision, and What the Fine Print Says
11 — When Medicare Advantage Fails: Disenrollment at the End of Life
12 — The Reform Proposals: From Audit Reform to Elimination
13 — What the Evidence Resolves — and What It Doesn’t
This article was researched and drafted with AI assistance under human review. See our full AI and editorial practices.